entity

ALS/FTD

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ALS/FTD: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

13Connections
1Hypotheses
2Analyses
0Outgoing
11Incoming

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

Novel Therapy Index

idea · 10647 words

Parkinson's Disease

disease · 8807 words

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (13)

SourceRelationTypeStr
polyunsaturated fatty acids (PUFAs)protects_againstcompound1.00
C9ORF72risk_factor_forgene0.95
FBLcontributes_togene0.95
VCPrisk_factor_forgene0.90
TDP-43 Dysfunctioncontributes_tomechanism0.90

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 0.601 neurodegeneration What are the mechanisms by which gut mic

Mentioning Analyses (2)

Scientific analyses that reference this entity

How does FUS loss-of-function in TAZ regulation contribute to ALS/FTD pathogenes

neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.606

How do pathological stress granules in neurodegeneration escape TRIM21/autophagy

neurodegeneration | 2026-04-06 | 0 hypotheses

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found